Home688319 • SHA
add
Chengdu Olymvax Biopharmaceuticals Inc
Nakaraang pagsara
¥24.60
Sakop ng araw
¥24.30 - ¥27.46
Sakop ng taon
¥10.07 - ¥34.68
Market cap
10.09B CNY
Average na Volume
6.04M
P/E ratio
171.00
Dividend yield
-
Primary exchange
SHA
Mga balita tungkol sa merkado
Bloomberg.com
23 minuto ang nakalipas
Japanese Stocks Rally, Bond Sale Sees Solid Demand: Markets Wrap
1.65%
0.30%
0.86%
Mga Financial
Income Statement
Kita
Net na kita
| (CNY) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 201.07M | 25.38% |
Gastos sa pagpapatakbo | 139.35M | 20.02% |
Net na kita | 34.28M | 7.22% |
Net profit margin | 17.05 | -14.49% |
Kita sa bawat share | — | — |
EBITDA | 54.11M | 44.28% |
Aktuwal na % ng binabayarang buwis | 17.41% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (CNY) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 217.27M | -19.37% |
Kabuuang asset | 1.94B | 13.90% |
Kabuuang sagutin | 976.63M | 24.15% |
Kabuuang equity | 968.34M | — |
Natitirang share | 405.93M | — |
Presyo para makapag-book | 10.42 | — |
Return on assets | 6.23% | — |
Return on capital | 8.74% | — |
Cash Flow
Net change in cash
| (CNY) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 34.28M | 7.22% |
Cash mula sa mga operasyon | 52.78M | 1,454.28% |
Cash mula sa pag-invest | -58.29M | -5.27% |
Cash mula sa financing | -9.14M | -157.22% |
Net change in cash | -14.65M | 66.15% |
Malayang cash flow | -5.15M | 93.94% |
Tungkol
Itinatag
Dis 11, 2009
Website
Mga Empleyado
463
